Overview of Dr. Hanash
Dr. Alan Hanash is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from University of Miami Leonard M. Miller School of Medicine and has been in practice 11 years. Dr. Hanash accepts several types of health insurance, listed below. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 50 publications and over 500 citings.
Office
1275 York Avenue
New York, NY 10065
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2008 - 2012
- University of ChicagoResidency, Internal Medicine, 2006 - 2008
- University of Miami Leonard M. Miller School of MedicineClass of 2006
Certifications & Licensure
- NY State Medical License 2008 - 2025
- IL State Medical License 2006 - 2009
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- STAT1 regulates immune-mediated intestinal stem cell proliferation and epithelial regeneration.Shuichiro Takashima, Roshan Sharma, Winston Chang, Marco Calafiore, Ya-Yuan Fu
Nature Communications. 2025-01-02 - Chemotherapy-induced intestinal epithelial damage directly promotes galectin-9-driven modulation of T cell behavior.Suze A Jansen, Alessandro Cutilli, Coco de Koning, Marliek van Hoesel, Cynthia L Frederiks
Iscience. 2024-06-21 - 1 citationsCorticosteroids impair epithelial regeneration in immune-mediated intestinal damage.Viktor Arnhold, Winston Y Chang, Suze A Jansen, Govindarajan Thangavelu, Marco Calafiore
The Journal of Clinical Investigation. 2024-02-13
Abstracts/Posters
- Graft Versus Host Disease Leads to Elimination of Tissue-Resident Innate Lymphoid Cells Following Experimental and Clinical Allogeneic TransplantationAlan M. Hanash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Mitochondrial Complex II in Intestinal Epithelial Cells Is a Critical Metabolic Checkpoint That Regulates Severity of Gastrointestinal Graft-Versus-Host DiseaseAlan M. Hanash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Insurance Accepted
- United Healthcare - Direct Choice Plus POSUnited Healthcare - Direct Options PPO
- Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: